Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Chung-Hwan Chen, Seung-Jae Lim, Jong-Keon Oh, Tsan-Wen Huang, Yuhong H Zeng, Meng-Ting Wu, Huilin L Yang, Jason Pui-Yin Cheung, Ji Wan Kim, Jeong Hee Han, Li Huo, Tsung-Jung Lin, Gang Zhou & Wen-Shuo Wu. (2020) Teriparatide in East Asian Postmenopausal Women with Osteoporosis in a Real-World Setting: A Baseline Analysis of the Asia and Latin America Fracture Observational Study (ALAFOS). Clinical Interventions in Aging 15, pages 111-121.
Read now
Read now
Chung-Hwan Chen, Abdulaziz H. Elsalmawy, Sophia Ish-Shalom, Seung-Jae Lim, Nadia S. Al-Ali, Joao L. Cunha-Borges, Huilin Yang, Noemí Casas, Lale Altan, Thomas Moll, Sirel Gurbuz, Alan J.M. Brnabic, Russel T. Burge & Fernando Marin. (2019) Study description and baseline characteristics of the population enrolled in a multinational, observational study of teriparatide in postmenopausal women with osteoporosis: the Asia and Latin America Fracture Observational Study (ALAFOS). Current Medical Research and Opinion 35:6, pages 1041-1049.
Read now
Read now
Atsushi Nishikawa, Takehiro Ishida, Masanori Taketsuna, Fumito Yoshiki & Hiroyuki Enomoto. (2016) Safety and effectiveness of daily teriparatide in a prospective observational study in patients with osteoporosis at high risk of fracture in Japan: final report. Clinical Interventions in Aging 11, pages 913-925.
Read now
Read now
Ö. Ljunggren, C. L. Benhamou, J. Dekker, G. Kapetanos, T. Kocjan, B. L. Langdahl, N. Napoli, H. Petto, T. Nikolić & E. Lindh. (2014) Study description and baseline characteristics of the population enrolled in a multinational observational study of extended teriparatide use (ExFOS). Current Medical Research and Opinion 30:8, pages 1607-1616.
Read now
Read now
Sophia Ish-Shalom, Constantin Dumitrache, Timour Fikry El-Husseini, Azza Hussein, Clare Barker & Imre Pavo. (2011) Postmenopausal women with osteoporosis: experience when treated with teriparatide in clinical practice. Current Medical Research and Opinion 27:2, pages 343-353.
Read now
Read now
Fredrik Borgström, Oskar Ström, Fernando Marin, Alexey Kutahov & Östen Ljunggren. (2010) Cost effectiveness of teriparatide and PTH(1-84) in the treatment of postmenopausal osteoporosis. Journal of Medical Economics 13:3, pages 381-392.
Read now
Read now
Harald JJ Verhaar & Willem F Lems. (2010) PTH analogues and osteoporotic fractures. Expert Opinion on Biological Therapy 10:9, pages 1387-1394.
Read now
Read now
Articles from other publishers (32)
Vitaley Kovalev, William H. Fang, Theresa Pak & Michael French. (2023) Pregnancy-Associated Osteoporosis: A Literature Review. Clinical Reviews in Bone and Mineral Metabolism 21:1-4, pages 14-20.
Crossref
Crossref
Hans P. Dimai & Astrid Fahrleitner-Pammer. (2022) Osteoporosis and Fragility Fractures: currently available pharmacological options and future directions. Best Practice & Research Clinical Rheumatology 36:3, pages 101780.
Crossref
Crossref
Jae Hyuk Yang, Incheol Kook, Byeong-Jik Kang, Wonjik Ju & Ye-Soo Park. (2022) Parathyroid Hormone Injection Versus Vertebroplasty in the Treatment of Osteoporotic Vertebral Fracture in Old Age: A Retrospective Study of 49 Patients. Journal of Korean Society of Spine Surgery 29:3, pages 52.
Crossref
Crossref
Barbara Hauser, Nerea Alonso & Philip L Riches. (2021) Review of Current Real-World Experience with Teriparatide as Treatment of Osteoporosis in Different Patient Groups. Journal of Clinical Medicine 10:7, pages 1403.
Crossref
Crossref
Abdul Aziz Elsalmawy, Nadia S. Al-Ali, Yasser Yaghi, Hussein Assaggaf, Ghassan Maalouf, Mir Sadat-Ali, Essam Zaher, Said Saghieh, Ahmed Mahmoud & Mohamed Taher. (2020) Middle East experience from the Asia And Latin America Fracture Observational Study (ALAFOS): Baseline characteristics of postmenopausal women with osteoporosis using teriparatide. Journal of International Medical Research 48:8, pages 030006052094085.
Crossref
Crossref
Joao L. Cunha-Borges, Guillermo Meléndez Mier, Noemí Casas, Adriana Medina, Jose Fernando Molina, Maria Laura García, Lindomar Guimarães Oliveria, Marcela S. Caselato, Angélica C. Cruz, Vanessa Ippolito & Sandra Flórez. (2019) Baseline characteristics of postmenopausal women with osteoporosis treated with teriparatide in a real-world setting in Latin America: a subregional analysis from the Asia and Latin America Fracture Observational Study (ALAFOS). Advances in Rheumatology 59:1.
Crossref
Crossref
Stuart Silverman, Bente L. Langdahl, Saeko Fujiwara, Ken Saag, Nicola Napoli, Satoshi Soen, Hiroyuki Enomoto, Thomas E. Melby, Damon P. Disch, Fernando Marin & John H. Krege. (2018) Reduction of Hip and Other Fractures in Patients Receiving Teriparatide in Real-World Clinical Practice: Integrated Analysis of Four Prospective Observational Studies. Calcified Tissue International 104:2, pages 193-200.
Crossref
Crossref
Salvatore Minisola, Cristiana Cipriani, Giada Della Grotta, Luciano Colangelo, Marco Occhiuto, Piergianni Biondi, Chiara Sonato, Evelina Vigna, Mirella Cilli & Jessica Pepe. (2019) Update on the safety and efficacy of teriparatide in the treatment of osteoporosis. Therapeutic Advances in Musculoskeletal Disease 11, pages 1759720X1987799.
Crossref
Crossref
Nicola Napoli, Bente. L. Langdahl, Östen Ljunggren, Eric Lespessailles, George Kapetanos, Tomaz Kocjan, Tatjana Nikolic, Pia Eiken, Helmut Petto, Thomas Moll, Erik Lindh & Fernando Marin. (2018) Effects of Teriparatide in Patients with Osteoporosis in Clinical Practice: 42-Month Results During and After Discontinuation of Treatment from the European Extended Forsteo® Observational Study (ExFOS). Calcified Tissue International 103:4, pages 359-371.
Crossref
Crossref
Fumito Yoshiki, Atsushi Nishikawa, Masanori Taketsuna, Kenta Kajimoto & Hiroyuki Enomoto. (2017) Efficacy and safety of teriparatide in bisphosphonate-pretreated and treatment-naive patients with osteoporosis at high risk of fracture: Post hoc analysis of a prospective observational study. Journal of Orthopaedic Science 22:2, pages 330-338.
Crossref
Crossref
Bente L. Langdahl, Östen Ljunggren, Claude-Laurent Benhamou, Fernando Marin, George Kapetanos, Tomaz Kocjan, Eric Lespessailles, Nicola Napoli, Tatjana Nikolic, Helmut Petto, Thomas Moll & Erik Lindh. (2016) Fracture Rate, Quality of Life and Back Pain in Patients with Osteoporosis Treated with Teriparatide: 24-Month Results from the Extended Forsteo Observational Study (ExFOS). Calcified Tissue International 99:3, pages 259-271.
Crossref
Crossref
Kyriakos Aloumanis, George Kapetanos, Nikolaos Bartzis & Vangelis Drossinos. (2015) Teriparatide use during an economic crisis: baseline data from the Greek cohort of the Extended Forsteo Observational Study (ExFOS). BMC Musculoskeletal Disorders 16:1.
Crossref
Crossref
Anne-Luise Thorsteinsson, Peter Vestergaard & Pia Eiken. (2015) Compliance and persistence with treatment with parathyroid hormone for osteoporosis. A Danish national register-based cohort study. Archives of Osteoporosis 10:1.
Crossref
Crossref
Gérald Rajzbaum, Franck Grados, David Evans, Soyi Liu-Leage, Helmut Petto & Béatrice Augendre-Ferrante. (2014) Persistance du traitement et évolution du risque de fracture, des douleurs rachidiennes et de la qualité de vie chez les patients traités par du tériparatide en pratique clinique de routine en France : résultats de l’étude observationnelle européenne Forsteo. Revue du Rhumatisme 81:5, pages 422-428.
Crossref
Crossref
Erik F. Eriksen, Tony M. Keaveny, Eileen R. Gallagher & John H. Krege. (2014) Literature review: The effects of teriparatide therapy at the hip in patients with osteoporosis. Bone 67, pages 246-256.
Crossref
Crossref
Gerald Rajzbaum, Franck Grados, David Evans, Soyi Liu-Leage, Helmut Petto & Béatrice Augendre-Ferrante. (2014) Persistance du traitement et évolution du risque de fracture, de maux de dos, et de qualité de vie chez les patients traités par du tériparatide en pratique clinique de routine en France : résultats de l’étude observationnelle européenne Forsteo. Revue du Rhumatisme 81:2, pages 170-176.
Crossref
Crossref
Gerald Rajzbaum, Franck Grados, David Evans, Soyi Liu-Leage, Helmut Petto & Béatrice Augendre-Ferrante. (2014) Treatment persistence and changes in fracture risk, back pain, and quality of life amongst patients treated with teriparatide in routine clinical care in France: Results from the European Forsteo Observational Study. Joint Bone Spine 81:1, pages 69-75.
Crossref
Crossref
Östen Ljunggren, Annabel Barrett, Ivaylo Stoykov, Bente L Langdahl, Willem F Lems, J Bernard Walsh, Astrid Fahrleitner-Pammer, Gerald Rajzbaum, Franz Jakob, Dimitrios Karras & Fernando Marin. (2013) Effective osteoporosis treatment with teriparatide is associated with enhanced quality of life in postmenopausal women with osteoporosis: the European Forsteo Observational Study. BMC Musculoskeletal Disorders 14:1.
Crossref
Crossref
S. Silverman, P. Miller, A. Sebba, M. Weitz, X. Wan, J. Alam, D. Masica, K. A. Taylor, V. A. Ruff & K. Krohn. (2013) The Direct Assessment of Nonvertebral Fractures in Community Experience (DANCE) study: 2-year nonvertebral fragility fracture results. Osteoporosis International 24:8, pages 2309-2317.
Crossref
Crossref
Christian Muschitz, Roland Kocijan, Astrid Fahrleitner-Pammer, Solveig Lung & Heinrich Resch. (2013) Antiresorptives overlapping ongoing teriparatide treatment result in additional increases in bone mineral density. Journal of Bone and Mineral Research 28:1, pages 196-205.
Crossref
Crossref
J. Bernard Walsh, Willem F. Lems, Dimitrios Karras, Bente L. Langdahl, Osten Ljunggren, Astrid Fahrleitner-Pammer, Annabel Barrett, Gerald Rajzbaum, Franz Jakob & Fernando Marin. (2012) Effectiveness of Teriparatide in Women Over 75 Years of Age with Severe Osteoporosis: 36-Month Results from the European Forsteo Observational Study (EFOS). Calcified Tissue International 90:5, pages 373-383.
Crossref
Crossref
DIMITRIOS KARRAS, IVAYLO STOYKOV, WILLEM F. LEMS, BENTE L. LANGDAHL, ÖSTEN LJUNGGREN, ANNABEL BARRETT, J. BERNARD WALSH, ASTRID FAHRLEITNER-PAMMER, GERALD RAJZBAUM, FRANZ JAKOB & FERNANDO MARIN. (2012) Effectiveness of Teriparatide in Postmenopausal Women with Osteoporosis and Glucocorticoid Use: 3-Year Results from the EFOS Study. The Journal of Rheumatology 39:3, pages 600-609.
Crossref
Crossref
C. M. McDonough, M. R. Grove, A. D. Elledge & A. N. A. Tosteson. (2011) Predicting EQ-5D-US and SF-6D societal health state values from the Osteoporosis Assessment Questionnaire. Osteoporosis International 23:2, pages 723-732.
Crossref
Crossref
F Jakob, H Oertel, B Langdahl, O Ljunggren, A Barrett, D Karras, J B Walsh, A Fahrleitner-Pammer, G Rajzbaum, C Barker, W F Lems & F Marin. (2012) Effects of teriparatide in postmenopausal women with osteoporosis pre-treated with bisphosphonates: 36-month results from the European Forsteo Observational Study. European Journal of Endocrinology 166:1, pages 87-97.
Crossref
Crossref
A. Fahrleitner-Pammer, B. L. Langdahl, F. Marin, F. Jakob, D. Karras, A. Barrett, Ö. Ljunggren, J. B. Walsh, G. Rajzbaum, C. Barker & W. F. Lems. (2010) Fracture rate and back pain during and after discontinuation of teriparatide: 36-month data from the European Forsteo Observational Study (EFOS). Osteoporosis International 22:10, pages 2709-2719.
Crossref
Crossref
K. Aloumanis, D. Karras, V. Drossinos, E. Korelis & A. Polydorakis. (2011) Fracture Incidence, Quality of Life, and Back Pain during 18-Months Treatment with Teriparatide in Greek Postmenopausal Women with Osteoporosis: Results from the European Forsteo Observational Study. Journal of Osteoporosis 2011, pages 1-8.
Crossref
Crossref
Bente L. Langdahl, Gerald Rajzbaum, Franz Jakob, Dimitrios Karras, Östen Ljunggren, Willem F. Lems, Astrid Fahrleitner-Pammer, J. Bernard Walsh, Clare Barker, Alexey Kutahov & Fernando Marin. (2009) Reduction in Fracture Rate and Back Pain and Increased Quality of Life in Postmenopausal Women Treated with Teriparatide: 18-Month Data from the European Forsteo Observational Study (EFOS). Calcified Tissue International 85:6, pages 484-493.
Crossref
Crossref
Sarah Derrett, James Black & G Peter Herbison. (2009) Outcome After Injury—A Systematic Literature Search of Studies Using the EQ-5D. Journal of Trauma: Injury, Infection & Critical Care 67:4, pages 883-890.
Crossref
Crossref
T. Peasgood, K. Herrmann, J. A. Kanis & J. E. Brazier. (2009) An updated systematic review of Health State Utility Values for osteoporosis related conditions. Osteoporosis International 20:6, pages 853-868.
Crossref
Crossref
Reiner Bartl & Bertha FrischReiner Bartl & Bertha Frisch. 2009. Osteoporosis. Osteoporosis
149
151
.
Sebastian Seitz, F. Timo Beil, Florian Barvencik, Christoph von Domarus, Johannes M. Rueger & Michael Amling. (2008) Postoperative Protocol in the Prevention of Fragility Fractures in Patients with Osteoporosis-Related Fractures. European Journal of Trauma and Emergency Surgery 34:6, pages 542-548.
Crossref
Crossref
Stephanie K A Blick, Sohita Dhillon & Susan J Keam. (2008) Teriparatide. Drugs 68:18, pages 2709-2737.
Crossref
Crossref